Risk of hepatocellular carcinoma among patients with hepatitis C virus cirrhosis treated with direct-acting antiviral therapy: An Australian experience

被引:0
|
作者
Snell, J. [1 ,2 ]
Hong, T. [1 ]
Glasgow, S. [1 ]
Papaluca, T. [1 ]
New, K. [1 ]
Mcclure, T. [1 ]
Bell, S. [1 ]
Demeduik, B. [1 ]
Jeremiah, C. [1 ]
Tran, S. [1 ,2 ]
Phan, D. [1 ,2 ]
Jarman, M. [1 ,2 ]
Iser, D. [1 ]
Lust, M. [1 ]
Shaw, G. [1 ]
Desmond, P. [1 ]
Croagh, C. [1 ]
Visvanathan, K. [1 ]
Howell, J. [1 ]
Ryan, M. [1 ,2 ]
Thompson, A. J. [1 ,2 ]
机构
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:80 / 81
页数:2
相关论文
共 50 条
  • [21] Dynamics of liver stiffness predicts hepatocellular carcinoma and ascites occurrence in patients with hepatitis C virus related cirrhosis treated with direct-acting antiviral agents
    Nicoletti, Alberto
    Ainora, Maria Elena
    Cintoni, Marco
    Garcovich, Matteo
    De Siena, Martina
    Funaro, Barbara
    Ponziani, Francesca
    Grieco, Antonio
    Riccardi, Laura
    Pompili, Maurizio
    Gasbarrini, Antonio
    Zocco, Maria Assunta
    JOURNAL OF HEPATOLOGY, 2022, 77 : S507 - S507
  • [22] Long-Term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection
    Muzica, Cristina Maria
    Stanciu, Carol
    Cijevschi-Prelipcean, Cristina
    Girleanu, Irina
    Huiban, Laura
    Petrea, Oana Cristina
    Singeap, Ana-Maria
    Cojocariu, Camelia
    Cuciureanu, Tudor
    Sfarti, Catalin
    Zenovia, Sebastian
    Chriac, Stefan
    Stefanescu, Gabriela
    Ciortescu, Irina
    Lupascu-Ursulescu, Corina
    Miftode, Egidia
    Trifan, Anca
    HEPATITIS MONTHLY, 2021, 21 (06)
  • [23] Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy
    Venkata Rajesh Konjeti
    Binu V. John
    Current Treatment Options in Gastroenterology, 2018, 16 (2) : 203 - 214
  • [24] Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
    Lin, Wei-Chen
    Lin, Yang-Sheng
    Chang, Chen-Wang
    Chang, Ching-Wei
    Wang, Tsang-En
    Wang, Horng-Yuan
    Chen, Ming-Jen
    PLOS ONE, 2020, 15 (05):
  • [25] Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
    Ahn, Young-Hwan
    Lee, Heirim
    Kim, Do Young
    Lee, Hye Won
    Yu, Su Jong
    Cho, Young Youn
    Jang, Jeong Won
    Jang, Byoung Kuk
    Kim, Chang Wook
    Kim, Hee Yeon
    Park, Hana
    Cho, Hyo Jung
    Park, Bumhee
    Kim, Soon Sun
    Cheong, Jae Youn
    GUT AND LIVER, 2021, 15 (03) : 410 - 419
  • [26] Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis
    Galati, Giovanni
    Muley, Moises
    Vigano, Mauro
    Iavarone, Massimo
    Vitale, Alessandro
    Dell'Unto, Chiara
    Lai, Quirino
    Cabibbo, Giuseppe
    Sacco, Rodolfo
    Villa, Erica
    Trevisani, Franco
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (07) : 603 - 610
  • [27] Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
    Calca, Rita
    Jorge, Cristina
    Lebre, Luis
    Cacheira, Eunice
    Querido, Sara
    Nascimento, Celia
    Adragao, Teresa
    Bruges, Margarida
    Weigert, Andre
    Machado, Domingos
    NEFROLOGIA, 2020, 40 (06): : 675 - 676
  • [28] Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis
    Ravi, Sujan
    Axley, Page
    Jones, Deann
    Kodali, Sudha
    Simpson, Heather
    McGuire, Brendan M.
    Singal, Ashwani K.
    GASTROENTEROLOGY, 2017, 152 (04) : 911 - 912
  • [29] Treatment of Hepatitis C in Patients with Cirrhosis: Remaining Challenges for Direct-Acting Antiviral Therapy
    Avik Majumdar
    Matthew T. Kitson
    Stuart K. Roberts
    Drugs, 2015, 75 : 823 - 834
  • [30] Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era
    Okumura, Kenji
    Sogawa, Hiroshi
    Samson, David
    Butler, Jonathan
    Veillette, Gregory
    John, Devon
    Diflo, Thomas
    Bodin, Roxana
    Wolf, David C.
    Latifi, Rifat
    Nishida, Seigo
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (07) : 1834 - 1838